Human medicines European public assessment report (EPAR): Symtuza, darunavir / cobicistat / emtricitabine / tenofovir alafenamide, HIV Infections, Date of authorisation: 20/09/2017, Revision: 6, Status: Authorised

Case Medical Research ◽

10.31525/cmr-56e4a1 ◽

2018 ◽

Author(s):

Keyword(s):

Hiv Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Tenofovir Alafenamide

Download Full-text

Human medicines European public assessment report (EPAR): Genvoya, elvitegravir / cobicistat / emtricitabine / tenofovir alafenamide, HIV Infections, Date of authorisation: 19/11/2015, Revision: 20, Status: Authorised

Case Medical Research ◽

10.31525/cmr-624f2d ◽

2019 ◽

Author(s):

Keyword(s):

Hiv Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Tenofovir Alafenamide

Download Full-text

Human medicines European public assessment report (EPAR): Odefsey, emtricitabine / rilpivirine / tenofovir alafenamide, HIV Infections, Date of authorisation: 21/06/2016, Revision: 14, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1a59726 ◽

2019 ◽

Author(s):

Keyword(s):

Hiv Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Tenofovir Alafenamide

Download Full-text

Human medicines European public assessment report (EPAR): Descovy, emtricitabine / tenofovir alafenamide, HIV Infections, Date of authorisation: 21/04/2016, Revision: 13, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1866f26 ◽

2019 ◽

Author(s):

Keyword(s):

Hiv Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Tenofovir Alafenamide

Download Full-text

Human medicines European public assessment report (EPAR): Genvoya, elvitegravir / cobicistat / emtricitabine / tenofovir alafenamide, HIV Infections, Date of authorisation: 19/11/2015, Revision: 19, Status: Authorised

Case Medical Research ◽

10.31525/cmr-616ac5 ◽

2019 ◽

Author(s):

Keyword(s):

Hiv Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Tenofovir Alafenamide

Download Full-text

Human medicines European public assessment report (EPAR): Biktarvy, bictegravir / emtricitabine / tenofovir alafenamide, HIV Infections, Date of authorisation: 21/06/2018, Revision: 1, Status: Authorised

Case Medical Research ◽

10.31525/cmr-60d98c ◽

2018 ◽

Author(s):

Keyword(s):

Hiv Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Tenofovir Alafenamide

Download Full-text

Human medicines European public assessment report (EPAR): Biktarvy, bictegravir / emtricitabine / tenofovir alafenamide, HIV Infections, Date of authorisation: 21/06/2018, Revision: 3, Status: Authorised

Case Medical Research ◽

10.31525/cmr-60fb94 ◽

2019 ◽

Author(s):

Keyword(s):

Hiv Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Tenofovir Alafenamide

Download Full-text

Human medicines European public assessment report (EPAR): Symtuza, darunavir / cobicistat / emtricitabine / tenofovir alafenamide, HIV Infections, Date of authorisation: 21/09/2017, Revision: 7, Status: Authorised

Case Medical Research ◽

10.31525/cmr-587252 ◽

2019 ◽

Author(s):

Keyword(s):

Hiv Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Tenofovir Alafenamide

Download Full-text

Human medicines European public assessment report (EPAR): Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva, efavirenz / emtricitabine / tenofovir disoproxil, HIV Infections, Date of authorisation: 17/07/2017, Revision: 4, Status: Authorised

Case Medical Research ◽

10.31525/cmr-399685 ◽

2019 ◽

Author(s):

Keyword(s):

Hiv Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Epivir, lamivudine, HIV Infections, Date of authorisation: 08/08/1996, Revision: 42, Status: Authorised

Case Medical Research ◽

10.31525/cmr-4d6de7 ◽

2019 ◽

Author(s):

Keyword(s):

Hiv Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Viread, tenofovir disoproxil, Hepatitis B, Chronic,HIV Infections, Date of authorisation: 04/02/2002, Revision: 51, Status: Authorised

Case Medical Research ◽

10.31525/cmr-39964c ◽

2019 ◽

Author(s):

Keyword(s):

Hepatitis B ◽

Hiv Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text